— Publications

First Nine Months Results 2018


Download
All financial reports


— Media releases


December 17, 2018

Valneva Initiates Phase 2 Clinical Development for its Lyme Disease Vaccine Candidate

Read more


— Financial calendar


Upcoming events
2018 Revenues
February 21, 2019




All dates




— Meet us

 
Lyme Disease

Download brochure









    

— Our responsibility

Committed to people, protecting lives and the environment


Learn more

play video Valneva's CEO Thomas Lingelbach
comments on Group Strategy

Subscribe to our Newsletter

mail-icon-lightblue.png


Contact Investor Relations

speech-balloon-icon-white.png

Please update your browser...